Adverse effect of thrombolytic; Adverse effect of tissue plasminogen activator; Adverse reaction to thrombolytic; Adverse reaction to tissue plasminogen activator
E934.4 Fibrinolysis-affecting drugs causing adverse effects in therapeutic use - ICD-9-CM Vol. 1 Diagnostic Codes - FindACode.com
Adverse effect of thrombolytic; Adverse effect of tissue plasminogen activator; Adverse reaction to thrombolytic; Adverse reaction to tissue plasminogen activator
Thrombolytic (Fibrinolytic) Drugs. Thrombolytic drugs are used to dissolve (lyse) blood clots (thrombi). Blood clots can occur in any vascular bed; . which can lead to the breakdown of circulating fibrinogen and cause an unwanted systemic fibrinolytic state. . Common adverse effects of all the thrombolytic drugs is bleeding complications related to systemic fibrinogenolysis and lysis of normal hemostatic plugs.
Information about Drug Side Effects. A side effect is usually regarded as an undesirable secondary effect which occurs in addition to the desired therapeutic effect of a drug or medication.
The acute, reversible gastrointestinal adverse effects seen with metformin may be minimised by administration with or after food, and by using lower dosages, increased slowly where necessary. . Unlike the sulphonylureas, metformin does not cause hypoglycaemia. . Type 2/drug therapy* Humans; Hypoglycemic Agents/therapeutic use; Metformin/pharmacokinetics; Metformin/pharmacology*
Which drugs affect potassium? Howes LG(1). . Diuretics remain the most important cause of drug-induced alterations. ACE inhibitors may produce hyperkalaemia, particularly in patients with autonomic neuropathy, . Cathartics/therapeutic use; Diuretics/adverse effects; Diuretics/therapeutic use; Drug Overdose; Humans; Hyperkalemia/chemically induced* Hyperkalemia/therapy;
Drugs, dietary changes, and other factors affect INR levels achieved with warfarin therapy. Instruct patients about prevention measures to minimize the risk of bleeding and to report immediately to their health care provider . Fibrinolytic therapy and ST-segment . the anticoagulants and the fibrinolytics requires constant clinical (and many times) laboratory monitoring as these drugs can cause serious adverse effects. In addition, the anticoagulants are very widely used and .
Adverse effects may cause complications of a disease or procedure and negatively affect its prognosis. . Adverse effects may cause a reversible or irreversible change, including an increase or decrease in the susceptibility of the individual to other chemicals, foods, or procedures, such as drug interactions . Adverse effects, like therapeutic effects of drugs, .
Drugs, dietary changes, and other factors affect INR levels achieved with Coumadin therapy [see Drug Interactions (7)]. . The amount of vitamin K in food may affect therapy with Coumadin. Advise patients taking Coumadin to eat a normal, . Coumadin may cause serious side effects including: .